QYResearch: The Restriction Endonucleases market is expected to reach USD 282 Million by 2022

PPT 模板下载 :www.1ppt.com/moban/ 

节日 PPT 模板 :www.1ppt.com/jieri/ 

PPT 背景图片 :www.1ppt.com/beijing/ 

优秀 PPT 下载 :www.1ppt.com/xiazai/ 

Word 教程 : www.1ppt.com/word/ 

资料下载 :www.1ppt.com/ziliao/ 

范文下载 :www.1ppt.com/fanwen/ 

教案下载 :www.1ppt.com/jiaoan/ 

字体下载 :www.1ppt.com/ziti/ 

行业 PPT 模板 :www.1ppt.com/hangye/ 

PPT 素材下载 :www.1ppt.com/sucai/ 

PPT 图表下载 :www.1ppt.com/tubiao/ 

PPT 教程 : www.1ppt.com/powerpoint/ 

Excel 教程 :www.1ppt.com/excel/ 

PPT 课件下载 :www.1ppt.com/kejian/ 

试卷下载 :www.1ppt.com/shiti/ 

QYResearch: The Restriction 

Endonucleases market is expected 

to reach USD 282 Million by 2022 

Custom Research|Research Report|Management Consulting|Seminar|Database

















Beijing Hengzhou Bozhi International Information 

Consulting 

Web: www.qyresearch.com | qyresearchglobal.com | 

qyresearcheurope.com | qyresearch.com | 

qyresearch.com/english | qyresearchjapan.com 

TEL:+86-13660489419, Office:+86-2086655165 

Media: press@qyresearch.com 

Marketing: sales@qyresearch.com 

Facebook: @QYResearchOfficial Twitter: @QYResearch_ 

Wechat Official Account: QYResearch, Weibo: 恒州博智

















QYResearch 

Restriction Endonuclease is an enzyme that cuts 

DNA at or near specific recognition nucleotide 

sequences known as restriction sites. They are 

the enzymes that are found in the bacteria and 

are harvested from them for their use in 

research and commercial aspects. Restriction 

enzymes are commonly classified into four types, 

which differ in their structure and whether they 

cut their DNA substrate at their recognition site, 

or if the recognition and cleavage sites are 

separate from one another.


















Till date more than 10,000 bacteria are screened for the presence of restriction enzymes 

and currently there are more than 2,500 restriction enzymes have been discovered along 

with over 250 distinct specificities in sequences. These enzymes are used in conventional 

cloning, deciphering epigenetic modifications, construction of DNA libraries and in vivo gene 

editing. The end users mainly are Academic & Research Institutes, Hospitals & Diagnostic 

Centers, and Pharmaceutical & Biotechnology companies. 

The Restriction Endonuclease industry is relatively concentrated, and the players mainly 

come from North America and Western Europe. In the world wide, major manufactures 

mainly are New England Biolabs, Thermo Fisher Scientific, Takara Bio, Illumina, Agilent 

Technologies, Roche, GE Healthcare, Promega Corporation, Qiagen, Jena Biosciences and etc.


















Factors such as regulatory policies and product approvals govern the market growth. 

Pharmaceutical and biotechnology companies along with academic research institutes 

utilize these REs in various activities. In 2016, the global market is about 3700 K Unit 

(Production), is 205 M USD (Revenue). Geographically, North America (40% revenue 

in2016) and Europe (32% revenue in2016) are the highest revenue generators in this 

market owing to increasing research and development activities followed by the presence 

of manufacturers in these regions. On the other hand Asia Pacific and Rest of the World 

(Row) regions present lucrative opportunities for the growth of this market due to 

increasing research projects funding by the respective governments followed by 

increasing commercial production of these enzymes.


















Full Report Link: http://www.qyresearchglobal.com/goods-1175832.html

QYResearch: The Restriction Endonucleases market is expected to reach USD 282 Million by 2022

Create successful ePaper yourself

Delete template?

Save as template?